Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Interim phase II data on miricorilant in NASH show liver fat reductions

May 7, 2021

Novel GLUT5 inhibitor molecule to treat fructose-induced diseases

May 6, 2021

Administration of 5,6-DiHETE, an endogenous TRPV4 antagonist, contributes to colitis healing in mice

May 4, 2021

Fat no proxy for quality in transplant livers

April 29, 2021

First patient enrolled in phase IIa study of CM-101 in NASH

April 27, 2021

Promising phase II data presented for olamkicept in ulcerative colitis

April 27, 2021

Enrollment opens in phase II study of RO-7049665 in autoimmune hepatitis

April 20, 2021

Medshine Discovery patents CRAC blockers

April 16, 2021

Thyroid hormone receptor beta agonists discovered at Sunshine Lake Pharma

April 15, 2021

First patient dosed in phase Ib/IIa study SYN-004 in allogeneic HCT recipients

April 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...